Immunohistochemical evaluation of the MRP2 expression was performed on 24 specimens of ovarian carcinoma, but this study also demonstrated no correlation with clinical response to platinum-based chemotherapy [44]. The gene discussed is ABCC2; the disease is ovarian carcinoma.